US Broker Ratings

Oruka Therapeutics, Inc. (ORKA): Investor Outlook on a Biotech with 61% Potential Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a Menlo Park-based clinical-stage biopharmaceutical company, has recently captured the attention of investors, thanks to an impressive potential upside of 61.14%. Specializing in the development..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 60% Upside Potential Amidst Revenue Challenges

Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, particularly in the specialized arena of public health threat preparedness...

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 167% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a prominent player in the biotechnology sector, has garnered significant attention from investors due to its promising therapeutic innovations and substantial potential upside. With a..

EyePoint, Inc. (EYPT) Stock Analysis: Unveiling a 223% Upside with Innovative Retinal Therapies

EyePoint, Inc. (EYPT), a biotechnology company rooted in the healthcare sector, is making significant strides in the treatment of serious retinal diseases. With a market capitalization of $1.05 billion, EyePoint’s..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: 68.73% Potential Upside Captivates Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company specializing in precision medicines, is making waves in the healthcare sector with its innovative approach to drug development. With a market..

Delcath Systems (DCTH): Analyst Consensus and 73% Potential Upside Drive Investor Interest

Delcath Systems, Inc. (NASDAQ: DCTH) has caught the eye of investors with a compelling narrative centered around its innovative medical solutions and promising market potential. Operating within the healthcare sector,..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a 34.82% Upside Potential in Biotechnology

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology sector with its focused approach on developing precision therapies for genetically defined diseases. With a market capitalization of $6.88..

Prothena Corporation (PRTA) Stock Analysis: Exploring the 150% Upside Potential in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA) is generating buzz in the biotechnology sector, boasting a compelling 150.88% potential upside, according to the latest analyst ratings. As a late-stage clinical biotechnology company..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a Potential -37% Downside Amidst Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, stands at an intriguing juncture for investors. With a market capitalization..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a 34.45% Potential Upside in the Biotech Sector

For investors eyeing opportunities in the healthcare sector, Septerna, Inc. (SEPN) presents a compelling case with its strong growth potential and promising pipeline. This clinical-stage biotechnology company, headquartered in South..

Immatics N.V. (IMTX) Stock Analysis: A Deep Dive into Its 103% Potential Upside

Investors seeking opportunities in the biotechnology space may find Immatics N.V. (NASDAQ: IMTX) worth their attention. As a clinical-stage biopharmaceutical company headquartered in Tübingen, Germany, Immatics is dedicated to advancing..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a 37% Potential Upside in CNS Therapeutics

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, has caught the attention of investors with its focus on developing groundbreaking treatments for central nervous system (CNS)..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 71.54% Potential Upside in Biotech

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing the attention of investors with a striking potential upside of 71.54%, according to analyst estimates. This commercial-stage biopharmaceutical company, headquartered in San Carlos,..

AngioDynamics, Inc. (ANGO)

⚠️ No article content returned.

..

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Innovative Therapies

PureTech Health plc (NASDAQ: PRTC), a prominent player in the biotechnology sector, continues to intrigue investors with its innovative approach to drug development and commercialization. Based in Boston, Massachusetts, PureTech..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a Potential 497% Upside in the Biotechnology Sector

Investors seeking lucrative opportunities in the biotechnology sector might find Upstream Bio, Inc. (NASDAQ: UPB) an intriguing prospect, especially given its staggering potential upside of nearly 498%. Despite a challenging..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: An Attractive 125% Upside Potential

Maze Therapeutics, Inc. (MAZE), a clinical-stage biopharmaceutical company specializing in small molecule precision medicines, offers a compelling investment opportunity with a potential upside of 125.88%. Operating in the biotechnology industry,..

Geron Corporation (GERN) Stock Analysis: Unveiling a 134% Potential Upside in the Biotech Sphere

As individual investors continually seek promising opportunities in the dynamic healthcare sector, Geron Corporation (NASDAQ: GERN) emerges as a noteworthy contender. Headquartered in Foster City, California, this biopharmaceutical company focuses..

RxSight, Inc. (RXST) Stock Analysis: Can this Medical Device Innovator Surge with a 56.96% Potential Upside?

RxSight, Inc. (RXST), a pioneering player in the healthcare sector, specializes in medical devices, specifically focusing on light adjustable intraocular lenses (LAL) used in cataract surgery. Headquartered in Aliso Viejo,..

Talkspace, Inc. (TALK) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Talkspace, Inc. (NASDAQ: TALK) is making waves in the healthcare sector as a virtual behavioral healthcare pioneer. With its comprehensive online platform, Talkspace connects patients with licensed mental health providers,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds